Stay updated with breaking news from Atacand Plus. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Wealth Alliance raised its position in shares of AstraZeneca PLC (NASDAQ:AZN – Free Report) by 26.3% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 13,712 shares of the company’s stock after buying an additional 2,856 shares during the quarter. Wealth Alliance’s […]
AstraZeneca (NASDAQ:AZN – Get Free Report) issued its earnings results on Wednesday. The company reported $0.73 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.74 by ($0.01), MarketWatch Earnings reports. AstraZeneca had a return on equity of 30.30% and a net margin of 13.10%. The business had revenue of $12.02 billion […]
Financial Security Advisor Inc. purchased a new position in AstraZeneca PLC (NASDAQ:AZN – Free Report) during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 6,514 shares of the company’s stock, valued at approximately $441,000. A number of other hedge funds also recently […]
KCM Investment Advisors LLC lessened its holdings in AstraZeneca PLC (NASDAQ:AZN – Free Report) by 6.0% during the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 7,718 shares of the company’s stock after selling 494 shares during the quarter. KCM Investment Advisors LLC’s holdings in AstraZeneca […]
Oppenheimer & Co. Inc. lifted its position in AstraZeneca PLC (NASDAQ:AZN – Free Report) by 51.8% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 14,424 shares of the company’s stock after buying an additional 4,919 shares during the […]